eli lilly and company retatrutide ESC 2024: improves lipid cardiovascular risk profile in Phase II trial Eli Lilly's retatrutide achieves 28%
Pay in 4 interest-free payments of $6.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




























